Response of red blood cell folate to intervention: Implications for folate recommendations for the prevention of neural tube defects

American Journal of Clinical Nutrition

Volumn 71, Issue 5 SUPPL., 2000, Pages

  McNulty, Helene ^a   Cuskelly, Geraldine J ^b   Ward, Mary ^b  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b NONE

Author keywords

Folate recommendations; Folic acid; Folic acid recommendations; Food folates; Fortification; Neural tube defects; NTDs; Women of reproductive age

Indexed keywords

ADULT; BIOAVAILABILITY; CONFERENCE PAPER; DIET SUPPLEMENTATION; DIETARY INTAKE; ERYTHROCYTE; FEMALE; FOLIC ACID BLOOD LEVEL; FOOD INTAKE; HUMAN; PATIENT COMPLIANCE; PREGNANCY; RISK FACTOR;

EID: 0034016537     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/71.5.1308s     Document Type: Conference Paper

References (34)

1. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991;338:131-7.
2. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-5.
3. Department of Health. Report from an Expert Advisory Group. Folic acid and the prevention of neural tube defects. London: Department of Health, 1992.
4. Public Health Service, Centers for Disease Control and Prevention. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Morbid Mortal Wkly Rep 1992;41:1-7.
5. National Health and Medical Research Council. Revised statement on the relationship between dietary folic acid and neural tube defects such as spina bifida. 115th session. Melbourne: NHMRC, 1993.
6. Grimes DA. Unplanned pregnancies in the US. Obstet Gynecol 1986;67:438-42.
7. Subar AF, Block G, James LD. Folate intake and food sources in the US population. Am J Clin Nutr 1989;50:508-16.
8. Gregory J, Foster K, Tyler H, Wiseman M. The dietary and nutritional survey of British adults. London: Her Majesty's Stationery Office, 1990.
9. Irish Nutrition and Dietetic Institute. Irish national nutrition survey. Dublin: Irish Nutrition and Dietetic Institute, 1990.
10. Cuskelly GJ, McNulty H, Scott JM. Effect of increasing dietary folate on red-cell folate: implications for prevention of neural tube defects. Lancet 1996;347:657-9.
11. Gregory JF. The bioavailability of folate. In: Bailey LB, ed. Folate in health and disease. New York: Marcel Dekker, 1995: 195-235.
12. Herbert V. Recommended dietary intakes (RDI) of folate in humans. Am J Clin Nutr 1987;45:661-70.
13. Clark MA, Fisk NM. Minimal compliance with Department of Health recommendation for routine folate prophylaxis to prevent neural tube defects. Br J Obstet Gynaecol 1994;101: 709-10.
14. Scott JM, Weir DG, Kirke PN. Prevention of neural tube defects with folic acid a success but.... Q J Med 1994;87:705-7.
15. Wild J, Sutcliffe M, Schorah CJ, Levene MI. Prevention of neural-tube defects. Lancet 1997;350:30-1.
16. Food and Drug Administration. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Fed Regist 1996;61:8781-9.
17. Gregory JF III. Bioavailability of folate. Eur J Clin Nutr 1997; 51(suppl):554-9.
18. Butterworth CE Jr, Tamura T. Folic acid safety and toxicity: a brief review. Am J Clin Nutr 1989;50:353-8.
19. Savage DG, Lindenbaum J. Folate-cobalamin interactions. In: Bailey LB, ed. Folate in health and disease. New York: Marcel Dekker, 1995:237-85.
20. Bower C, Wald NJ. Vitamin B-12 deficiency and the fortification of food with folic acid. Eur J Clin Nutr 1995;49:787-93.
21. Oakley GP Jr. Let's increase folic acid fortification and include vitamin B-12. Am J Clin Nutr 1997;65:1889-90.
22. Daly S, Mills JL, Molloy AM, et al. Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet 1997;350:1666-9.
23. Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM. Folate levels and neural tube defects, implications for prevention. JAMA 1995; 274:1698-702.
24. Roe DA. Drug-folate interrelationships: historical aspects and current concerns. In: Picciano MF, Stockstad ELR, Gregory JF, eds. Folic acid metabolism in health and disease. New York: Wiley-Liss, 1990:277-87.
25. Halsted CH. Alcohol and folate interactions: clinical implications. In: Bailey LB, ed. Folate in health and disease. New York: Marcel Dekker, 1995:313-27.
26. Sauberlich HE. Folate status of US population groups. In: Bailey LB, ed. Folate in health and disease. New York: Marcel Dekker, 1995:171-94.
27. Ek J, Magnus EM. Plasma and red cell folate during normal pregnancies. Acta Obstet Gynecol Scand 1981;60:247-51.
28. Chanarin L. Folate and cobalamin. Clin Haematol 1985;14:629-41.
29. Goldenberg RL, Tamura T, Cliver SP, Cutter CR, Hoffman JH, Copper RL. Serum folate and fetal growth retardation: a matter of compliance? Obstet Gynecol 1992;79:719-22.
30. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 1995;274:1049-57.
31. Ubbink JB, Vermaak WJ, Van der Merwe A, Becker PJ, Delport R, Potiger HC. Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J Nutr 1994;124:1927-33.
32. Brattstrorn L, Israellson B, Jeppson J, Hultberg B. Folic acid - an innocuous means to reduce plasma homocysteine. Scand J Clin Lab Invest 1998;48:215-21.
33. Homocysteine Lowering Trialists' Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ 1998;316:894-8.
34. Ward M, McNulty H, McPartlin JM, Strain JJ, Weir DG, Scott JM. Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid. Q J Med 1997; 90:519-24.